Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Arcadia Biosciences (RKDA) Operating Margin (2016 - 2025)

Historic Operating Margin for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to 88.48%.

  • Arcadia Biosciences' Operating Margin rose 260300.0% to 88.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 65.76%, marking a year-over-year decrease of 101800.0%. This contributed to the annual value of 72.31% for FY2024, which is 646900.0% up from last year.
  • Per Arcadia Biosciences' latest filing, its Operating Margin stood at 88.48% for Q3 2025, which was up 260300.0% from 34.43% recorded in Q2 2025.
  • Arcadia Biosciences' 5-year Operating Margin high stood at 151.61% for Q2 2024, and its period low was 643.24% during Q1 2021.
  • Its 5-year average for Operating Margin is 177.42%, with a median of 143.57% in 2022.
  • The largest annual percentage gain for Arcadia Biosciences' Operating Margin in the last 5 years was 29777900bps (2021), contrasted with its biggest fall of -4503300bps (2021).
  • Quarter analysis of 5 years shows Arcadia Biosciences' Operating Margin stood at 321.02% in 2021, then skyrocketed by 125bps to 80.14% in 2022, then crashed by -292bps to 153.54% in 2023, then decreased by -22bps to 187.42% in 2024, then surged by 53bps to 88.48% in 2025.
  • Its last three reported values are 88.48% in Q3 2025, 34.43% for Q2 2025, and 44.17% during Q1 2025.